Rejuvenate Bio | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,599 results for “Rejuvenate Bio”

Rejuvenate Biomed Initiates Phase II Trial of RJx-01 for COPD-Related Muscle Weakness

Rejuvenate Biomed Partners with NIHR Leicester BRC for Phase 2 Trial of Novel COPD-Related Sarcopenia Treatment

Rejuvenate Biomed Completes Patient Recruitment for Phase 2 Trial of First-in-Class Sarcopenia Drug RJx-01

Rejuvenate Bio Closes $6 Million Financing, Partners with Merck Animal Health to Advance Gene Therapy for Chronic Age-Related Diseases in Companion Animals

Sarcopenia Pipeline Shows Robust Growth with 18+ Pharma Companies Developing Novel Therapies

TECregen Secures €11M Seed Funding and Appoints New CEO to Advance Thymus Regeneration Therapeutics

STGen Bio's Songdo Plant Secures FDA cGMP Approval, Expanding Global Reach

Life Biosciences Secures First FDA Approval for Human Epigenetic Reprogramming Trial to Reverse Vision Loss

Tolerance Bio Partners with ZipCode Bio to Develop Targeted Thymus Therapeutics for Immune Aging

Mabwell and Aditum Bio Launch Kalexo Bio to Advance Novel siRNA Therapy for Cardiovascular Disease

Page 1 of 185